| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |